Derek Cole | executive |
Todd Watanabe | executive |
Todd Edwards | executive |
Patrick Burnett | executive |
Tyler Van Buren | analyst |
Uy Ear | analyst |
Stephen Sloan | analyst |
John Smither | executive |
Colleen Garvey | analyst |
Serge Belanger | analyst |
Vikram Purohit | analyst |
Hyun Kim | analyst |
Good day, and welcome to the Arcutis Biotherapeutics 2023 Fourth Quarter and Full Year Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the call over to Derek Cole, Arcutis, Investor Relations. Please go ahead.
Thank you, Andrew.